These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 23878061

  • 1. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J, Ding J, Huang L, Tian X, Shi X, Zhi L, Song J, Zhang Y, Gao X, Yao Z, Jing X, Yang J.
    Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
    [Abstract] [Full Text] [Related]

  • 2. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD, Shen F, Ji JS, Zheng K, Huang M, Wu JC.
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [Abstract] [Full Text] [Related]

  • 3. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [Abstract] [Full Text] [Related]

  • 4. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
    Zhang D, Liu J, Wang Y, Chen J, Chen T.
    J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
    [Abstract] [Full Text] [Related]

  • 5. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo.
    Yao M, Wang L, Yang J, Yan X, Cai Y, Yao D.
    Tumour Biol; 2016 Nov; 37(11):14677-14686. PubMed ID: 27623941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, Huang MC.
    Cancer Res; 2013 Sep 01; 73(17):5580-90. PubMed ID: 23832667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.
    Adamek A, Kasprzak A, Mikoś H, Przybyszewska W, Seraszek-Jaros A, Czajka A, Sterzyńska K, Mozer-Lisewska I.
    Oncol Rep; 2013 Sep 01; 30(3):1337-45. PubMed ID: 23784592
    [Abstract] [Full Text] [Related]

  • 11. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
    Zhang S, Li J, Wang X.
    Tumour Biol; 2016 Oct 01; 37(10):14059-14067. PubMed ID: 27507614
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC.
    Oncotarget; 2015 Dec 01; 6(38):40920-33. PubMed ID: 26506518
    [Abstract] [Full Text] [Related]

  • 14. Construction of a recombinant eukaryotic human ZHX1 gene expression plasmid and the role of ZHX1 in hepatocellular carcinoma.
    Wang J, Liu D, Liang X, Gao L, Yue X, Yang Y, Ma C, Liu J.
    Mol Med Rep; 2013 Nov 01; 8(5):1531-6. PubMed ID: 24064680
    [Abstract] [Full Text] [Related]

  • 15. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ, Chin-Sheng H, Kuo LJ, Wei PL, Lu HH, Chen HA, Liu TZ, Liu JJ, Liu DZ, Ho YS, Wu CH, Chang YJ.
    Ann Surg Oncol; 2012 Jan 01; 19(1):336-43. PubMed ID: 21516372
    [Abstract] [Full Text] [Related]

  • 16. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S, Zhang F, Miao L, Zhang H, Fan Z, Wang X, Ji G.
    Oncol Rep; 2008 Nov 01; 20(5):1053-9. PubMed ID: 18949401
    [Abstract] [Full Text] [Related]

  • 17. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW.
    Int J Oncol; 2009 Dec 01; 35(6):1257-64. PubMed ID: 19885547
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.
    Ai Zheng; 2006 May 01; 25(5):526-32. PubMed ID: 16687068
    [Abstract] [Full Text] [Related]

  • 19. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
    Jie X, Lang C, Jian Q, Chaoqun L, Dehua Y, Yi S, Yanping J, Luokun X, Qiuping Z, Hui W, Feili G, Boquan J, Youxin J, Jinquan T.
    Oncogene; 2007 Aug 23; 26(39):5741-51. PubMed ID: 17369855
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ, Zhang JP.
    Chin Med J (Engl); 2011 Nov 23; 124(22):3794-9. PubMed ID: 22340243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.